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Summary
Background: Although coronary artery disease (CAD) is less prevalent in women than in men,
early mortality rate is higher in women with CAD than in men with CAD following coronary
revascularization. In terms of the long-term outcomes after coronary revascularization, limited
data are available. Especially, in the Japanese CAD population, no data about sex-related differ-
ences in long-term outcomes after coronary revascularization exist. The aim of this study was
to compare long-term outcomes between men and women following complete revascularization
in Japanese patients with CAD.
Methods: We collected data from 1836 consecutive patients who underwent complete revas-
cularization by percutaneous coronary interventions and/or bypass surgeries. All-cause and
cardiac mortality and the incidence of stroke were compared between men and women. In
addition to the univariate analysis, a multivariate Cox regression was carried out in order to
adjust for differences in baseline characteristics.
Results: There were 274 female patients (14.9%). They were older, had greater total cholesterol
levels, and were more likely to have multivessel disease than men. During follow-up [mean (SD),
11.4 (2.9) years], 412 patients died (including 131 patients who died of cardiac causes), and
130 had a stroke. In the multivariate analysis, female patients did not have a signiﬁcant risk for
all-cause mortality (hazard ratio [HR], 1.01; p = 0.993), cardiac mortality (HR, 1.41; p = 0.256),
or stroke (HR, 0.71; p = 0.309).
∗ Corresponding author. Tel.: +81 3 5802 1056; fax: +81 3 5689 0627.
E-mail addresses: ktmmy@med.juntendo.ac.jp, ktmmy@juntendo.ac.jp (K. Miyauchi).
914-5087/$ — see front matter © 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
oi:10.1016/j.jjcc.2011.03.003
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Conclusions: In the present study involving CAD patients who underwent complete revascular-
ization, we showed that, although women were older and had more unfavorable risk proﬁles,
they did not have a greater risk of long-term all-cause mortality, cardiac mortality, or stroke
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ﬁcation of Diseases, Ninth Revision (ICD-9) codes 410—414,
785.51, and 798. Stroke was deﬁned, based on the World
Health Organization stroke deﬁnition [33], as a focal neu-incidence, compared to men
© 2011 Japanese College of C
Introduction
In individuals who are less than 60 years of age, the inci-
dence of coronary artery disease (CAD) is markedly lower in
women than in men [1]. Because there is a 20-year delay
of CAD onset in women compared with men, it has been
suggested that women may have some mechanism that pro-
tects them against CAD before menopause [2]. Therefore,
the prevalence of CAD is generally lower in women than in
men, although the morbidity of women due to CAD has been
increasing recently.
Women with CAD are more likely to have worse out-
comes. In particular, women have a greater early mortality
compared to men with CAD, following coronary revascu-
larization with either percutaneous coronary interventions
(PCI) or coronary artery bypass surgeries (CABG) [3—12]. It
has been suggested that this is related to the less favor-
able risk proﬁles of women. For example, women who
receive coronary revascularization are generally older and
have more comorbidities and more extended CAD than men
[7,8,13—15]. On the other hand, the sex differences in
outcomes following coronary revascularization are dimin-
ished after adjustment for baseline confounders or if only
the long-term outcomes are examined [16—21]. Thus, being
a woman in itself does not seem to pose an indepen-
dent risk for poor outcome, and it has been suggested
that safer or advanced treatment procedures, including
newer PCI techniques, complete revascularization, the use
of arterial grafts, and the off-pump technique, might
decrease the disparity in mortality between women and men
[17,22—25].
Limited data in regard to sex differences in the out-
come in patients with CAD or those who undergo coronary
revascularization are available for the Japanese popula-
tion [26—28]. In addition, no data on whether there are
sex differences in long-term outcomes in patients follow-
ing complete revascularization exist. Therefore, the aim
of this study was to compare long-term outcomes between
men and women following complete revascularization in the
Japanese CAD patient population.
Methods
Subjects and baseline data collection
Data from consecutive patients who had undergone surgi-
cal and/or percutaneous coronary revascularization at the
Juntendo University Hospital between January 1984 and
December 1992 were analyzed. Patients who had achieved
complete coronary revascularization, which was deﬁned
as no un-bypassed major vessels with a ≥50% stenosis,
were enrolled [29,30]. Patients who had other known life-
threatening diseases at baseline and who had associated
complex cardiac procedures, such as valve replacement or
r
2
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neurysm repair, at the time of the surgical revasculariza-
ion were excluded.
Demographic data, including age, sex, and body mass
ndex (BMI), coronary risk factors (blood pressure, lipid
roﬁle, fasting plasma glucose levels, smoking status, and
amily history of CAD), medication use, revascularization
rocedure-related factors, comorbidities (prior myocardial
nfarction or stroke, current dialysis treatment, or atrial ﬁb-
illation) were collected in the database at our institution.
For all analyses, patients were divided into 2 groups
ccording to gender. During the study period, each patient
as further categorized based on the presence of coro-
ary risk factors using the following criteria. Patients
ere considered hypertensive if their systolic blood pres-
ure was ≥140mmHg, their diastolic blood pressure was
90mmHg, or they were currently being treated with anti-
ypertensive medications. Patients were considered to have
iabetes mellitus if their fasting plasma glucose levels were
126mg/dL or they were currently being treated with oral
ypoglycemic drugs or insulin injections [31]. A current
moker was deﬁned as one who smoked at the time of
omplete revascularization or who had quit smoking within
year before the complete revascularization. Estimated
lomerular ﬁltration rate (eGFR) was obtained by using the
peciﬁc equation for Japanese [32]. Patients were consid-
red to have atrial ﬁbrillation if they had persistent or
ermanent atrial ﬁbrillation at the time of the procedure.
atients with isolated PCI were those in whom complete
evascularization was achieved by PCI without any bypass
rafting. This study was performed according to the ethi-
al policies of Juntendo University and was approved by the
nternal review board.
utcomes
urvival data and data about the incidence of stroke were
ollected by serial contact (every 5 years) with the patients
r their families until September 30, 2000 and from the
edical records of patients who had died and from those
ho continued to undergo follow-up examinations at our
ospital. Information about the circumstances and date of
eath were obtained from the families of patients who died
t home, and details of the cardiac events or the cause
f death was supplied by other hospitals or clinics where
atients had been admitted. Mortality data were catego-
ized according to the cause of death, such as death from
ll causes or cardiac deaths using the International Classi-ological disorder with rapid onset that persisted at least
4 h or until death. This included ischemic and hemorrhagic
troke (intracerebral hemorrhage or subarachnoid hemor-
hage), but excluded transient ischemic attack (deﬁned as
1 H. Sato et al.
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Figure 1 Survival curves (all-cause death) of men and women.
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Table 2. In terms of all-cause mortality, the hazard ratio
(HR) for women was not signiﬁcant in the unadjusted anal-
ysis (HR, 0.86; p = 0.305). However, in the age-adjusted
model, women had a signiﬁcantly lower risk for all-cause60
ocal neurological symptoms lasting less than 24 h), subdural
emorrhage, epidural hemorrhage, poisoning, or symptoms
aused by trauma. The stroke diagnoses were veriﬁed by
eurologists. In this analysis, the composite incidence of
atal and non-fatal stroke was recorded as the clinical out-
ome.
tatistical analysis
ontinuous variables are expressed as mean (SD) and
ompared using a Student’s t-test. Categorical data are dis-
layed as frequencies and percentages and compared using
he chi-square test or Fisher’s exact test. A Kaplan—Meier
stimate with a log-rank test and Cox proportional haz-
rds models were used for survival analyses. Univariate and
ultivariate Cox proportional hazard regressions were per-
ormed in order to examine the unadjusted and adjusted
isks for all-cause and cardiac death and the composite inci-
ence of fatal and non-fatal stroke in women compared
ith that in men. In the multivariate analyses, we created
he following 2 adjusted models: (1) an age-adjusted model
n which only age was included; and (2) a full-adjusted
odel in which age, BMI, diabetes mellitus, hyperten-
ion, total and high-density lipoprotein (HDL) cholesterol
evels, triglyceride levels, smoking status, eGFR, atrial ﬁb-
illation, previous myocardial infarction, previous stroke,
ultivessel disease, presence or absence of left main trunk
LMT) lesions, presence or absence of arterial bypass to
he left anterior descending (LAD) artery, left ventricular
jection fraction (LVEF), whether complete revasculariza-
ion was achieved using isolated PCI, and the use of aspirin,
ngiotensin-converting enzyme (ACE) inhibitors, -blockers,
alcium channel blockers, and statins were included, in
ddition to gender. The assumption of proportional haz-
rds was assessed and veriﬁed using a log-minus-log survival
raph. p-Values of <0.05 were considered signiﬁcant. All
ata were analyzed using Dr. SPSS II for Windows (SPSS Inc.,
hicago, IL, USA).
esults
aseline characteristics
verall, complete revascularization was achieved in 1836
atients during the study period. Among them, 274 (14.9%)
atients were women. Baseline characteristics and clini-
al events during follow-up [mean (SD), 11.4 (2.9) years]
ere collected for all the patients. The baseline charac-
eristics of men and women are shown in Table 1. Women
ere signiﬁcantly older and had a lower BMI than men. In
erms of lipid proﬁle, women had greater levels of total
nd HDL cholesterol but had lower triglyceride levels than
hose in men. Women were less likely to be hypertensive and
iabetic, although these trends were not statistically signif-
cant. Women had greater level of eGFR than that in men.
oreover, they were less likely to be a current smoker and to
e given ACE inhibitors than men. There were no signiﬁcant
ifferences between the 2 groups in any other variables.
ll patients underwent PCI with balloon angioplasty; no
atients received stent implantation, since stents were not
et available at the time of complete revascularization. All
F
T
f
prom all-cause death between men and women (log-rank test,
= 0.305).
ABG procedures were performed under on-pump conven-
ional cardiopulmonary bypass.
urvival analyses
uring follow-up, 412 patients (22.4%) died from all causes,
31 patients (7.2%) died from cardiac causes, and 130 (7.1%)
troke events (95 ischemic and 35 hemorrhagic) occurred.
he Kaplan—Meier curves are shown in Figs. 1—3. The results
f the unadjusted and adjusted analyses are summarized inigure 2 Survival curves (cardiac death) of men and women.
here was no signiﬁcant difference in the cumulative survival
rom cardiac death between men and women (log-rank test,
= 0.562).
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Table 1 Baseline characteristics.
Men (N = 1562) Women (N = 274) p-Value
Age, years 58.6 (8.8) 62.5 (8.1) <0.001
BMI, kg/m2 23.7 (2.6) 22.9 (2.7) <0.001
Diabetes mellitus, n [%] 587 [37.6] 116 [42.3] 0.154
Hypertension, n [%] 1046 [67.0] 192 [70.1] 0.346
Total cholesterol, mg/dL 220.0 (49.0) 229.3 (49.1) 0.004
HDL cholesterol, mg/dL 42.0 (12.6) 46.7 (13.3) <0.001
Triglycerides, mg/dL 170.4 (104.3) 146.0 (69.5) <0.001
Current smoker, n [%] 1260 [80.7] 99 [36.1] <0.001
Family history of CAD, n [%] 484 [31.0] 91 [33.2] 0.508
eGFR 79.5 (28.9) 109.1 (50.1) <0.001
On dialysis, n [%] 25 [1.6] 2 [0.7] 0.405
Previous MI, n [%] 756 [48.4] 125 [45.6] 0.433
Previous stroke, n [%] 73 [4.7] 9 [3.3] 0.385
Atrial ﬁbrillation, n [%] 205 [13.1] 26 [9.5] 0.115
Multivessel disease, n [%] 1163 [74.5] 222 [81.0] 0.024
LMT lesion, n [%] 123 [7.9] 26 [9.5] 0.434
Arterial bypass to LAD, n [%] 508 [32.5] 100 [36.5] 0.223
LVEF, % 64.3 (12.9) 65.1 (12.9) 0.352
Revascularization — isolated PCI, n [%] 1103 [70.6] 198 [72.3] 0.630
Medications, n [%]
Aspirin 1112 [71.2] 201 [73.4] 0.509
ACE inhibitors 85 [5.4] 5 [1.8] 0.016
Beta blockers 444 [28.4] 75 [27.4] 0.776
Calcium channel blockers 329 [21.1] 52 [19.0] 0.481
Statins 274 [17.5] 54 [19.7] 0.157
Continuous variables are expressed as mean (SD). BMI, body mass index; HDL, high-density lipoprotein; CAD, coronary artery disease;
tion;
tion
beGFR, estimated glomerular ﬁltration rate; MI, myocardial infarc
ventricular ejection fraction; PCI, percutaneous coronary interven
mortality than men (HR, 0.69; p = 0.015). When we fully
adjusted for differences in the baseline characteristics, risk
for all-cause mortality in women was not different from
that in men (HR, 1.01; p = 0.176). There were no differences
in the risk of cardiac mortality between men and women
(
p
n
(
Table 2 Hazard ratios for women for all-cause mortality, cardiac
All-cause death Cardiac deat
HR 95%CI p HR 95
Unadjusted
Men 1.00 Reference 1.00 R
Women 0.86 0.64—1.15 0.305 0.86 0.
Age-adjusted
Men 1.00 Reference 1.00 R
Women 0.69 0.52—0.93 0.015 0.73 0.
Full-adjusted
Men 1.00 Reference 1.00 R
Women 1.01 0.72—1.39 0.993 1.41 0.
The full-adjusted model included sex and age; BMI; diabetes mellitus; h
smoking, eGFR; atrial ﬁbrillation; previous MI; previous stroke; multi
absence of arterial bypass to the LAD; LVEF; whether complete revascu
ACE inhibitors, -blockers, calcium channel blockers, or statins. HR, h
high density lipoprotein; eGFR, estimated glomerular ﬁltration rate; M
descending; LVEF, left ventricular ejection fraction; PCI, percutaneousLMT, left main trunk; LAD, left anterior descending; LVEF, left
; ACE, angiotensin-converting enzyme.
oth in the unadjusted (HR, 0.86; p = 0.562), age-adjusted
HR, 0.73; p = 0.234), and full-adjusted analyses (HR, 1.41;
= 0.256). For the risk of stroke incidence, women had a sig-
iﬁcantly lower risk than men in the age-adjusted analysis
HR, 0.50; p = 0.024), but this difference was not statistically
mortality, and the incidence of stroke.
h Stroke
%CI p HR 95%CI p
eference 1.00 Reference
51—1.45 0.562 0.60 0.33—1.09 0.096
eference 1.00 Reference
43—1.23 0.234 0.50 0.28—0.92 0.024
eference 1.00 Reference
78—2.53 0.256 0.71 0.36—1.38 0.309
ypertension; total and HDL cholesterol levels; triglyceride levels;
vessel disease; presence or absence of LMT lesion; presence or
larization was achieved using isolated PCI; and the use of aspirin,
azard ratio; CI, conﬁdence interval; BMI, body mass index; HDL,
I, myocardial infarction; LMT, left main trunk; LAD, left anterior
coronary intervention; ACE, angiotensin-converting enzyme.
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Figure 3 Stroke-free survival curves of men and women.
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ihere was no signiﬁcant difference in the cumulative stroke-
ree survival between men and women (log-rank test, p = 0.092).
igniﬁcant in both the unadjusted (HR, 0.60; p = 0.096) and
ull-adjusted analyses (HR, 0.71; p = 0.309). There were no
ex-related differences in the type of stroke events (hem-
rrhagic or ischemic), with 32 hemorrhagic and 86 ischemic
trokes in men and 3 hemorrhagic and 9 ischemic strokes in
omen.
iscussion
his study showed two important ﬁndings. First, there were
o sex-related differences in the long-term outcome after
oronary revascularization among the Japanese CAD patient
opulation, despite the fact that women have more unfa-
orable baseline risk proﬁles. Second, in patients who had
ndergone complete revascularization, which is generally
ecommended to decrease the disparity between men and
omen in early mortality following coronary revasculariza-
ion, long-term outcomes in women were not different from
hose in men.
Many studies have shown sex-related differences in the
hort-term outcome following coronary revascularization
3—12]. Most of these studies have been reported mainly by
nstitutions in Western countries and suggest that, compared
o men, women have poorer short-term outcomes follow-
ng either PCI or CABG in association with their unfavorable
aseline risk proﬁles, which include older age and higher
ncidences of hypercholesterolemia, diabetes mellitus, and
xtended CAD. Furthermore, since women generally have
smaller body habitus and, consequently, smaller coronary
essel size than men, these factors might also play a role
n the short-term mortality differences between the sexes.
ndeed, in the present study, in addition to their smaller
MI, women were older, had greater total cholesterol lev-
ls, and were more likely to have multivessel disease than
en. Although some reports have shown that sex-related
ifferences remained after adjustment for baseline risk pro-
les [5,6,10—12], most of the other studies have indicated
hat the disparities between men and women disappeared
fter adjustment for baseline risk proﬁles [3,4,7—9]. Simi-
o
l
(H. Sato et al.
arly, a recent report on Korean patients with acute coronary
yndrome (ACS) showed that women with ACS were more
ikely to have vulnerable plaque components, which were
ssessed by virtual histology-intravascular ultrasound, com-
ared to men with ACS. However, these ﬁndings may be
xplained by a higher prevalence of diabetes and greater
ystemic inﬂammation in women than in men with ACS [34].
his ﬁnding is similar to Japanese patients undergoing coro-
ary revascularization. Hirakawa et al. [35] showed that,
mong patients who had undergone PCI, women were older,
ere more likely to have unfavorable risk proﬁles, and had
orse in-hospital mortality than men, before adjustment
or the baseline proﬁles. However, after adjustment, these
ex-related differences in the short-term outcomes disap-
eared. Furthermore, Fukui and Takanashi [36] recently
howed that among patients who had undergone CABG, the
omen were older and were more likely to non-electively
ndergo CABG, compared to men. After adjustment for
hese baseline differences, women were not inferior with
espect to their short-term mortality but still had a greater
isadvantage in the incidence of cerebrovascular events
hen compared with men. Taken together, these ﬁndings
uggest that being a woman may not be an independent risk
actor for a short-term poor outcome, except for the cere-
rovascular events, and the other unfavorable risk proﬁles in
omen might play a more important role in the differences
etween sexes with respect to the short-term outcomes.
When we focus on the long-term outcomes following
oronary revascularization, women showed comparable, or,
ather, better outcomes than men despite women’s unfa-
orable baseline risk proﬁles [16—21]. Most of the studies,
hich have examined sex-related differences in long-term
utcomes following PCI or CABG, were from Western coun-
ries and showed no sex-related differences in the long-term
utcomes following coronary revascularization, especially
fter adjustment for baseline risk proﬁles. Considering these
acts, again, it is the unfavorable baseline risk proﬁles per
e, and not being a woman, that may affect the long-term
utcomes. Here, we showed that the long-term outcomes
ollowing coronary revascularization did not differ between
en and women, even in a Japanese CAD patient population,
hich is consistent with the ﬁndings from previous studies
rom Western countries.
These ﬁndings also suggest that the modiﬁcation of
omen’s unfavorable baseline risk proﬁles might affect the
ifference in long-term outcomes. For example, the use of
afer and more advanced or solid treatment procedures,
uch as newer PCI techniques, complete revascularization,
he use of arterial grafts and the off-pump technique,
ight decrease the disparity in the short-term and, in turn,
n the subsequent long-term outcomes between women
nd men. Indeed, there are supportive data suggesting
hat those procedures altered women’s poor short-term
utcomes [17,22—25]. However, there are no data show-
ng that complete revascularization might affect such
ex-related differences in long-term outcomes. Here, we
ompared long-term outcomes after complete revascular-
zation between men and women and found that long-term
utcomes in women were not different from those in men.
Achieving complete revascularization might prevent at
east one characteristic of women’s unfavorable risk proﬁles
i.e. more extended CAD) and thereby diminish differences
tion
[
[
[
[
[
[
[
[Long-term outcomes of women with CAD after revasculariza
in short-term outcomes [22]. Therefore, analyzing data
about patients who achieved complete coronary revascu-
larization may provide more of an estimation of the effect
of being a woman, in itself, on the long-term outcomes.
Actually, the present study showed that no differences in
long-term outcomes existed between the genders. Another
possible explanation why women with complete revascu-
larization have comparable long-term outcomes to men,
despite being older and more likely to have unfavorable
risk proﬁles, may be that women with CAD might be more
motivated to modify the CAD risk factors and to be more
compliant with medications or instructions by cardiologists
than men with CAD. Nevertheless, this is the ﬁrst study
investigating the presence or absence of sex-related dif-
ferences in long-term outcomes among Japanese patients
following complete coronary revascularization.
Study limitations
The present study has several limitations. First, this is a
retrospective analysis of a cohort in a single institution.
Therefore, the data from the present study should be inter-
preted with caution. Second, balloon angioplasty was the
sole PCI used in all patients, and all the CABG procedures
were performed under on-pump conventional cardiopul-
monary bypass. It is difﬁcult to determine whether the use
of stents, including drug-eluting stents and off-pump CABG,
which are common in the recent era of coronary revascular-
ization, would have affected the results. Third, although we
adjusted for the inﬂuence of baseline medical treatments in
the multivariable analyses and veriﬁed assumptions of the
proportional hazard model for these treatments at baseline,
the crossovers in drug usage or further interventions for
recurrent CAD during the follow-up period may affect the
results. It is also difﬁcult to determine the relative impor-
tance of improvements in both operator skills and adjunctive
drug therapies. Therefore, in the recent era of medical
treatment and coronary revascularization, further investi-
gation is needed to clarify whether sex differences exist
in the long-term outcomes after revascularization among
the Japanese CAD population. Third, the number of cases
examined 15 years after revascularization was markedly
reduced. Therefore, the existence of gender-related dif-
ferences in really long-term (>15 years) outcomes remains
unclear. Finally, the average life expectancy of women is
generally longer than that of men in Japan. This should also
be taken into account.
Conclusion
In the present study involving consecutive patients who
underwent complete revascularization, we showed that
although women were older and had more unfavorable risk
proﬁles, being a woman does not have greater risks for long-
term all-cause or cardiac mortality or for stroke incidence,
compared to men.References
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